[PDF] Top 20 FORMULATION DEVELOPMENT AND EVALUATION OF MODIFIED RELEASE ANTISPASMODIC PELLETS

... the formulation department should be ...The formulation is subjected to accelerated stability conditions (40 0 C±2 0 C/75% RH ...drug release was found to be increased a little more at 40 0 C ... See full document

... Moreover, pellets being multi-unit particulate dosage forms, can offer some additional advantages such as easy dispersion in GI tract, increased drug absorption, and minimum potential for local irritation of the ... See full document

... coated pellets were cured overnight in an oven with an air-circulating fan at 40˚C and stored in a desiccator before initiating the dissolution ...of pellets required 20% concentration of Ethyl cellulose ... See full document

... the formulation development and clinical testing; it is also an obstacle at the beginning when screening new compounds for pharmacological ...technological formulation approaches to make such poorly ... See full document

... extended release Venlafaxine hydrochloride pellets: The compositions for all the batches are given in Table ...Spheronized pellets were dried in a drying oven at 60°C for 4 h. These dried ... See full document

... Screw-fed extruders have screws that rotate along the horizontal axis and hence transport the material horizontally; they may be axial or radial screw extruders. Axial extruders, which have a die plate that is positioned ... See full document

... Sustained release preparations are useful to reduce the dosage frequency to improve patient ...Sustained release pellets are easy to formulate by incorporating drug molecule in a slowly ... See full document

... of pellets, Factors that mostly influence pellet production have been studied and found to be reformulation parameters, irrespective of the solid dosage form, influence both the process and the quality of the ... See full document

... are modified by coating, matrix formation or encapsulation by considering the physicochemical properties of drug, physiology of mucosal membrane and delivery devices or matrices 1-6 ...drug release, ... See full document

... . Pellets have many advantages they Disperse freely in the GI& invariably maximize drug absorption, Reduce peak plasma fluctuation, Minimize potential side effects without lowering bioavailability Avoiding ... See full document

... of modified release multiple dosage form with different release patterns such as immediate and sustained release pattern, taste masking of the drugs, gastro retentive floating and ...of ... See full document

... the formulation must be chemically, physically and microbiologically ...the development of conventional applications (Lee and Robinson, 2000) ...its formulation needs to be technically ...drug ... See full document

... be modified in many ways to achieve the desired drug release ...drug release profile in multiparticulates is to coat ...sustained release, targeted release, delayed release and ... See full document

... Any formulation variable or process parameter with an higher RPN was regarded as a potential critical factor, that is, potential risks are evaluated by subsequent process characterization studies since it possibly ... See full document

... towards development of modified – release or so – called specialized drug delivery ...immediate- release component have sometimes been termed prolonged ...release. Modified ... See full document

... The drug/carrier mix is typically processed with a twin-screw extruder. The drug/carrier mix is simultaneously melted, homogenized and then extruded and shaped as tablets, granules, pellets, sheets, sticks or ... See full document

... drug release at 0.5hr), Q10 ( drug release at the 10hr), Q18 (drug release at 18hr), and f2 value were selected as dependent variables ...The formulation layout of the factorial batches ... See full document

... work, modified release gliclazide once a daily tablet were designed for non-insulin dependent diabetes for better patient compliance by direct compression method, HPMC was used as polymer, Dibasic calcium ... See full document

... Optimized formulation C3 (17% w/w Hydroxy Propyl Methyl Cellulose, Methacrylic acid copolymer type C (30% aqueous dispersion), 10% TEC polymers) has successfully delayed the drug release and followed zero ... See full document

... The tablets of different formulations were subjected to various evaluation tests, such as thickness, diameter, weight variation, drug content, hardness, friability, and in vitro dissolution. The thickness of the ... See full document